Craig Kevin James (CIK 2049601) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-29). Recent activity: Buy ATAI (33,051 shares), Buy ATAI (9,528 shares), Sell ATAI (42,579 shares), Buy ATAI (27,280 shares), Buy ATAI (15,299 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-29 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 33,051 | $49,576 |
| 2026-06-29 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 9,528 | $11,243 |
| 2026-06-29 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Sell | 42,579 | $192,031 |
| 2026-04-22 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 27,280 | $40,920 |
| 2026-04-22 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 15,299 | $28,150 |
| 2026-04-22 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Sell | 42,579 | $212,895 |
| 2026-03-24 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 76,224 | $89,944 |
| 2026-03-24 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Buy | 23,776 | $35,664 |
| 2026-03-24 | AtaiBeckley Inc. (ATAI) | Chief Medical Officer | Sell | 100,000 | $355,000 |
| 2025-03-24 | ATAI Life Sciences N.V. (ATAI) | Chief Medical Officer | Sell | 11,563 | $15,610 |
| 2025-03-19 | ATAI Life Sciences N.V. (ATAI) | Chief Medical Officer | Buy | 20,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-29